Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Faiq Gorial
In this randomized double blind placebo-controlled pilot study (Phase I study) we will assess the efficacy and safety of adjuvant use Niclosamide With Etanercept in Rheumatoid Arthritis.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients with RA, as defined by the American College of Rheumatology (ACR) 1987 revised criteria or ACR/EULAR 2010,
Severly Active RA by calculating either DAS28 or SDAI or CDAI.
Patient selected are those who started etanercept for less than 3months and still active.
You may not be if
Patients on nonsteroidal anti-inflammatory drugs (NSAID) 2 days before entry into this study. or methotrexate (MTX)..
Patients with hypersensitivity or severe adverse effects to niclosamide .
Renal impairment.
Hepatic impairment.
Pregnancy or a desire to become pregnant.
Breast feeding.
Patients with Juvenile RA \[16 years old or younger\].
Patients using other conventional disease modifying antirheumatic drugs (DMARDs).
Patients on steroid.
Patients with coexistence other connective tissue diseases or hypothyroid disease.
Patient with mild or inactive RA.
Clareo Health | Niclosamide With Etanercept in Rheumatoid Arthritis
